Bagsværd, Denmark, 14 October 2022 – Novo Nordisk today announced that the acquisition of Forma Therapeutics Holdings, Inc. (Forma), announced on 1 September 2022, has been completed. Following the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results